Keyword: Piramal

Chemistry & Life Sciences

Addressing The Pharma Innovation Gap

13.06.2016 - Since the beginning of the 21st century, pharma M&A activity has exploded. Mergers and acquisitions, layoffs, and outsourcing of research and manufacturing have become common place...

News

India’s Piramal Healthcare Invests in Scotland

20.11.2015 - Piramal Healthcare UK Ltd., a subsidiary of the Indian Piramal group, is spending £2 million to expand its manufacturing base for antibody drug conjugates at Grangemouth, Scotland...

News

Aesica appoints VP, Business Development and Business Development Director for Finished Dose

20.10.2014 - Aesica announced the appointment of two senior business development positions. Detlef Behrens has been appointed to the role of Vice President, Business Development, Finished Dose...

News

Slow Approvals Put India's Drug Trials Industry at Risk

13.02.2013 - Slower government approval for testing new medicines is threatening India's aspirations to be a fast-growing, low-cost hub for clinical trials, and has prompted some drugs firms to...

News

Fujifilm Diosynth Biotechnologies, Piramal Announce Strategic Alliance

24.10.2012 - Fujifilm Diosynth Biotechnologies has announced it has entered into a strategic alliance with Piramal Healthcare UK, whereby the two parties will offer the seamless contract...

News

India's Piramal Healthcare to Buy U.S. Firm to Boost R&D

16.05.2012 - Indian drugmaker Piramal Healthcare has agreed to buy a U.S.-based healthcare data provider for $635 million to boost research and development, the company said on Wednesday, a...

News

Piramal Sees $1.5 Billion Revenue from Potential Alzheimer's Drug

16.04.2012 - Indian drugmaker Piramal Healthcare sees revenue potential of $1.5 billion from its new florbetaben molecule, a possible Alzheimer's treatment acquired by the company in a deal...

News

India's Piramal to Boost Financial Business

22.11.2011 - Diversified Indian conglomerate Piramal Group plans to lend up to $193 million to real estate projects in the current fiscal year to March as it focuses on building its newly...